Antibody Mediated Rejection of Lung Transplant
1 clinical trials · Condition
◉ Watch Antibody Mediated Rejection of Lung Transplant
| Record | Firm | Date |
|---|---|---|
| A Phase 1 Clinical Trial of Siltuximab for the Treatment of Antibody-Mediated Rejection After Lung Transplantation (NCT06990711) | Washington University School of Medicine | 2025-11-06 |
Track Antibody Mediated Rejection of Lung Transplant automatically
Every clearance here is in the API, with alerts when new ones post.